| Issue Date | Title | Author(s) |
| 2018 | Benefit of adjuvant radiotherapy following narrow-margin hepatectomy in patients with intrahepatic cholangiocarcinoma that adhere to major vessels | Zheng, Xuan; Chen, Bo; Wu, Jian-Xiong; Jia, Angela Y.; Rong, Wei-Qi; Wang, Li-Ming; Wu, Fan; Zhao, Yu-Ting; Li, Ye-Xiong; Wang, Wei-Hu |
| Mar-2023 | Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma | Liu, Jia-Xin; Liu, Xin; Yang, Yong; Liu, Wei-Ping; Wang, Ying; He, Xia; Zhang, Li-Ling; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Su, Hang; Zhang, Yu-Jing; Zhu, Jun; Qi, Shu-Nan; Li, Ye-Xiong; Song, Yu-Qin |
| Aug-2021 | Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer | Yang, Jing; Qi, Shu-Nan; Fang, Hui; Song, Yong-Wen; Jin, Jing; Liu, Yue-Ping; Wang, Wei-Hu; Yang, Yong; Tang, Yu; Ren, Hua; Chen, Bo; Lu, Ning-Ning; Tang, Yuan; Li, Ning; Jing, Hao; Wang, Shu-Lian; Li, Ye-Xiong |
| Sep-2023 | Evidence of cure for extranodal nasal-type natural killer/T-cell lymphoma with current treatment: an analysis of the CLCG database | Liu, Xin; Zhang, Li-Ling; Qu, Bao-Lin; Zhong, Qiu-Zi; Qian, Li-Ting; Yang, Yong; Hou, Xiao-Rong; Qiao, Xue-Ying; Wang, Hua; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Zhang, Xi-Mei; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; Chen, Fan; Yin, Lin; He, Xia; Cai, Shang; Li, Ye-Xiong; Qi, Shu-Nan |
| 14-Jul-2020 | First-line non-anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG | Qi, Shu-Nan; Yang, Yong; Song, Yu-Qin; Wang, Ying; He, Xia; Hu, Chen; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Huang, Hui-Qiang; Zhang, Yu-Jing; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Xu, Li-Ming; Yuan, Zhi-Yong; Su, Hang; Zhu, Jun; Li, Ye-Xiong |
| 2018 | Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition) | Zhou, Jian; Sun, Hui-Chuan; Wang, Zheng; Cong, Wen-Ming; Wang, Jian-Hua; Zeng, Meng-Su; Yang, Jia-Mei; Bie, Ping; Liu, Lian-Xin; Wen, Tian-Fu; Han, Guo-Hong; Wang, Mao-Qiang; Liu, Rui-Bao; Lu, Li-Gong; Ren, Zheng-Gang; Chen, Min-Shan; Zeng, Zhao-Chong; Liang, Ping; Liang, Chang-Hong; Chen, Min; Yan, Fu-Hua; Wang, Wen-Ping; Ji, Yuan; Cheng, Wen-Wu; Dai, Chao-Liu; Jia, Wei-Dong; Li, Ya-Ming; Li, Ye-Xiong; Liang, Jun; Liu, Tian-Shu; Lv, Guo-Yue; Mao, Yi-Lei; Ren, Wei-Xin; Shi, Hong-Cheng; Wang, Wen-Tao; Wang, Xiao-Ying; Xing, Bao-Cai; Xu, Jian-Mi |
| Aug-2020 | Inhibition of EPS8L3 suppresses liver cancer progression and enhances efficacy of sorafenib treatment | Chen, Bo; Pan, Yan; Xu, Xin; Wu, Fan; Zheng, Xuan; Chen, Si-Ye; Zhao, Yu-Ting; Huang, Zhou; Cheng, Shu-Hui; Liu, Jian-Xiang; Wang, Wei-Hu; Li, Ye-Xiong |
| Aug-2021 | A novel nomogram for predicting locoregional recurrence risk in breast cancer patients treated with neoadjuvant chemotherapy and mastectomy | Huang, Zhou; Shi, Mei; Wang, Wei-Hu; Shen, Liang-Fang; Tang, Yu; Rong, Qing-Lin; Zhu, Li; Huang, Xiao-Bo; Tie, Jian; Chen, Jia-Yi; Zhang, Jun; Wu, Hong-Fen; Cheng, Jing; Liu, Min; Ma, Chang-Ying; Wang, Shu-Lian; Li, Ye-Xiong |
| 2017 | Observation of different tumor motion magnitude within liver and estimate of internal motion margins in postoperative patients with hepatocellular carcinoma | Zhao, Yu-Ting; Liu, Zhi-Kai; Wu, Qiu-Wen; Dai, Jian-Rong; Zhang, Tao; Jia, Angela Y.; Jin, Jing; Wang, Shu-Lian; Li, Ye-Xiong; Wang, Wei-Hu |
| 2024 | Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma | Luo, Fei; Zhong, Qiu-Zi; Liu, Xin; Hou, Xiao-Rong; Qian, Li-Ting; Qiao, Xue-Ying; Wang, Hua; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Zhang, Hui-Lai; Zhang, Xi-Mei; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; He, Xia; Zhang, Li-Ling; Qu, Bao-Lin; Yang, Yong; Hu, Chen; Deng, Min; Wang, Shu-Lian; Qi, Shu-Nan; Li, Ye-Xiong |
| 2018 | Phase 2 Study of First-line Intensity Modulated Radiation Therapy Followed by Gemcitabine, Dexamethasone, and Cisplatin for High-Risk, Early Stage Extranodal Nasal-Type NK/T-Cell Lymphoma: The GREEN Study | Qi, Fei; Wang, Wei-Hu; He, Xiao-Hui; Chen, Bo; Gui, Lin; Fang, Hui; Liu, Peng; Wang, Shu-Lian; Yang, Jian-Liang; Song, Yong-Wen; Yang, Sheng; Qi, Shu-Nan; Zhou, Sheng-Yu; Li, Ye-Xiong; Dong, Mei |
| 15-Nov-2020 | Postmastectomy Radiation Therapy Based on Pathologic Nodal Status in Clinical Node-Positive Stage II to III Breast Cancer Treated with Neoadjuvant Chemotherapy | Huang, Zhou; Zhu, Li; Huang, Xiao-Bo; Tang, Yu; Rong, Qing-Lin; Shi, Mei; Wang, Wei-Hu; Tie, Jian; Shen, Liang-Fang; Chen, Jia-Yi; Zhang, Jun; Wu, Hong-Fen; Cheng, Jing; Liu, Min; Tan, Yu-Ting; Ma, Chang-Ying; Wang, Shu-Lian; Li, Ye-Xiong |
| Jun-2021 | Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Yang, Yong; Wang, Ying; Liu, Xin; He, Xia; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Xu, Li-Ming; Su, Hang; Song, Yu-Qin; Zhu, Jun; Zhang, Yu-Jing; Huang, Hui-Qiang; Hu, Chen; Qi, Shu-Nan; Li, Ye-Xiong |
| 2018 | Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG) | Deng, Xiu-Wen; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Su, Hang; Wang, Ying; He, Xia; Xu, Li-Ming; Yuan, Zhi-Yong; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Zhang, Yu-Jing; Zhu, Yuan; Cao, Jian-Zhong; Lan, Sheng-Min; Dong, Mei; Qi, Shu-Nan; Yang, Yong; Li, Ye-Xiong |
| Sep-2020 | Risk-based, response-adapted therapy for early-stage extranodal nasal-typeNK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study | Qi, Shu-Nan; Yang, Yong; Zhang, Yu-Jing; Huang, Hui-Qiang; Wang, Ying; He, Xia; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Zhu, Yuan; Cao, Jian-Zhong; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Xu, Li-Ming; Yuan, Zhi-Yong; Su, Hang; Song, Yu-Qin; Zhu, Jun; Hu, Chen; Li, Ye-Xiong |
| Mar-2020 | Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making | Chen, Si-Ye; Yang, Yong; Qi, Shu-Nan; Wang, Ying; Hu, Chen; He, Xia; Zhang, Li-Ling; Wu, Gang; Qu, Bao-Lin; Qian, Li-Ting; Hou, Xiao-Rong; Zhang, Fu-Quan; Qiao, Xue-Ying; Wang, Hua; Li, Gao-Feng; Zhang, Yu-Jing; Zhu, Yuan; Cao, Jian-Zhong; Lan, Sheng-Min; Wu, Jun-Xin; Wu, Tao; Zhu, Su-Yu; Shi, Mei; Xu, Li-Ming; Yuan, Zhi-Yong; Yahalom, Joachim; Tsang, Richard; Song, Yu-Qin; Zhu, Jun; Su, Hang; Li, Ye-Xiong |
